Full results from two Lilly trials of the novel triple hormone receptor agonist show reductions in A1c, osteoarthritis knee pain, and obstructive sleep apnea.

Patients with obesity and type 2 diabetes have more favorable QOL outcomes taking a GLP-1 than those with either condition alone or with multiple comorbidities.

More nurses regularly take on second shifts but as the practice becomes normalized, is this best for patients?

Phase 3 data on sunvozertinib for EGFR exon 20 insertions and sacituzumab tirumotecan plus pembrolizumab for PD-L1-positive ...

The first known analysis of pooled worldwide population-based data on dementia with Lewy bodies shows incidence is higher ...

New research suggests that time and aging change how people deal with regrets. Here’s what it could mean for doctors.

Early peanut oral immunotherapy may confer lasting immune benefits, with most young patients continuing to consume peanuts ...

Both T1D and T2D are linked to a higher incidence of subtrochanteric or femoral shaft and hip fractures, but after adjusting ...

A pilot study shows that a urine-based metabolite panel accurately distinguishes children with autism from typically ...

Disease activity, organ involvement, and treatment choice all shape infection risk in lupus and rheumatoid arthritis, with ...

Weekly subcutaneous injections of the novel B-cell inhibitor obexelimab significantly reduces disease flares and lowers toxic ...

For men with localized prostate cancer, proton therapy looks no better than IMRT when it comes to 3-year biochemical ...